Stelios Tzannis

USPTO Granted Patents = 27 (Patent Applications = 4)

CIPO Patents = 4

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 5.9

ph-index = 13

Forward Citations = 1,075(Granted Patents)

Location History:

Newark, CA (US) (2007 - 2016)
Petaluma, CA (US) (2014 - 2020)

Company Filing History:

19 out of 26

Acelrx Pharmaceuticals, Inc.

Aceirx Pharmaceuticals, Inc.

patent

4. 1 out of 1

Acelrx Pharmaceutical, Inc.

patent

5. 1 out of 832,680

Other

patents

Years Active: 2007-2020

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10709881 - Apparatus for administering small volume oral transmucosal dosage forms (2020-07-14),

2. 10507180 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-12-17),

3. 10342762 - Small-volume oral transmucosal dosage forms (2019-07-09),

4. 10245228 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-04-02),

5. 9744129 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2017-08-29),

6. 9642996 - Methods and apparatus for administering small volume oral transmucosal dosage forms (2017-05-09),

7. 9320710 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2016-04-26),

8. 9289583 - Methods for administering small volume oral transmucosal dosage forms using a dispensing device (2016-03-22),

9. 9066847 - Storage and dispensing devices for administration of oral transmucosal dosage forms (2015-06-30),

10. 8956602 - Delivery of drugs (2015-02-17),

11. 8945592 - Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same (2015-02-03),

12. 8865743 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2014-10-21),

13. 8865211 - Bioadhesive drug formulations for oral transmucosal delivery (2014-10-21),

14. 8778394 - Small-volume oral transmucosal dosage forms (2014-07-15),

15. 8778393 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2014-07-15),

Title: The Inventor Stelios Tzannis: Revolutionizing Technology

Introduction: Stelios Tzannis is a visionary inventor based in Newark, CA, whose groundbreaking work has significantly impacted the technological landscape. With a passion for innovation and a keen eye for detail, he has dedicated his career to creating cutting-edge solutions that push the boundaries of what is possible.

Latest Patents: Stelios Tzannis holds several patents in the field of electronics and telecommunications, including a recent patent for a revolutionary wireless charging technology that promises to change the way we power our devices.

Career Highlights: Throughout his illustrious career, Stelios Tzannis has worked with leading tech companies to develop innovative products that have garnered international acclaim. His ability to blend creativity with technical expertise has led to the successful commercialization of numerous inventions.

Collaborations: Stelios Tzannis has collaborated with top researchers, engineers, and designers to bring his ideas to life. His collaborative spirit and commitment to excellence have resulted in the creation of groundbreaking technologies that have reshaped industries.

Conclusion: Stelios Tzannis continues to be a driving force in the world of technology, inspiring others with his innovative spirit and dedication to pushing the boundaries of what is possible. His contributions have left an indelible mark on the field of electronics and serve as a testament to the power of innovation.

This text is generated by artificial intelligence and may not be accurate.